Loading...

215 posters, 5 topics, 22 sessions, 596 authors, 283 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2025

May 15 - 16, 2025 | ICC, 2 Lanyon Place, Belfast BT1 3WH

Obstetric Anaesthesia Annual Scientific Meeting 2025 banner

6773100

Unilateral Horner's Syndrome in a normal BMI patient following labour epidural analgesia: A case report

Part of Topic

Case report

  A Case Report: Unilateral Horner’s Syndrome in a Normal BMI Patient Following Labour Epidural Analgesia

 Hira, P1 ; Lassota-Korba, B1 ; Gouda, A1 ; Das, S2 ; Chatterjee, N3

1Yeovil District Hospital, Somerset NHS Foundation Trust; 2Buckinghamshire Healthcare NHS Trust; 3Oxford University Hospitals NHS Foundation Trust

 INTRODUCTION

Horner’s Syndrome (HS) is a rare complication of lumbar epidural analgesia during labour, caused by unintended cephalad spread of local anaesthetic agents.

 CASE PRESENTATION

32-year-old, G1P0, BMI 25.2, mild scoliosis

Epidural: L3–L4, levobupivacaine 0.1% + fentanyl 2mcg/ml via PCEA

Onset: 3 hours post-epidural – left eye itching, ptosis, miosis

No haemodynamic instability or foetal compromise

Analgesia level: T2 (left), T4 (right)

Epidural reduced, remifentanil PCA started

Symptoms resolved in 24 hours

 DISCUSSION

 

  1. Incidence of HS with epidurals: 0.13–1.5% (up to 4% in C-sections)
  2. Risk factors: Spinal anomalies like Scoliosis, supine position, anatomical variations, pregnancy-related physiological changes
  3. Pathophysiology: Common: Cephalad spread of local anaesthetic to cervical sympathetic chain, due to reduction of epidural cavity, rhythmic upward movement of LA owing to uterine contraction. Uncommon: Epidural Septae (2%), Subdural injection of LA
  4. Management: Early detection and reassurance, dose reduction, alternative analgesia

 CONCLUSION:

Horner’s Syndrome, although rare and self-limiting, warrants vigilant monitoring, especially in patients with spinal deformities. Prompt adjustment of epidural infusion and reassurance can effectively manage the condition

 CONSENT: We explained and obtained consent from the patient for publication.

 CONFLICTS OF INTERESTS: There are no conflicts of interest

 REFERENCES

  1. Chambers DJ, Bhatia K. Int J Obstet Anaesth. 2018;35:75–97
  2. L. Peene et al. Acta Anaesth. Belg. 2020;71:43–47
  3. Alshoubi A, Newhide D. Cureus. 2022;14(7):e77252
  4. Agarwal D, Mohta M, Tyagi A, Sethi AK; Anaesth Intensive Care 2010; 38: 20-26
  5. Sharma R., Chatterjee J. and Edmonds K. 2010; BMJ Case Reports. bcr0120102698


oaa2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.